Veris Health and The Ohio State University Partner on Cancer Care
Strategic Partnership Overview
PAVmed Inc. (NASDAQ: PAVM), known for its innovative medical technology solutions, has embarked on an exciting journey alongside its subsidiary Veris Health Inc. and The Ohio State University Comprehensive Cancer Center. This collaboration aims to improve personalized cancer care for patients undergoing systemic therapy, marking a significant advancement in cancer treatment strategies.
Enhancing Cancer Care with the Veris Cancer Care Platform
The Veris Cancer Care Platform is at the core of this collaboration, designed to deliver tailored cancer care through improved patient monitoring. The system allows for remote collection of physiological data, symptom reporting, and telehealth functions that seamlessly integrate with electronic health records, thus creating a comprehensive framework for patient care.
Features of the Platform
This innovative platform provides cancer patients with a VerisBox™, a set of connected health devices that securely relay physiological data to healthcare providers via a cloud-based system. Patients benefit from a user-friendly smartphone application that enables them to keep track of their symptoms and health status, fostering active participation in their treatment process.
Clinical Deployment at The James
Phase one of the partnership focuses on operationalizing the Veris platform at The James Cancer Hospital, one of the largest academic cancer centers in the country. Brian deGuzman, M.D., Chief Operating Officer of Veris Health, expressed enthusiasm about the commercial phase, emphasizing the opportunity to reach the platform's full potential for improving patient outcomes.
Commitment to Patient-Centered Care
David Cohn, M.D., M.B.A., CMO at The James, echoed this sentiment, stating that the expansion to a full engagement allows for enhanced connection with patients beyond traditional hospital visits. This partnership not only enhances clinical workflows but also promotes patient well-being through better management of their health data.
Future Developments and Innovations
Veris Health is also pioneering the development of an implantable physiological monitor aimed at further enhancing patient care. This monitor will be designed to work alongside existing treatment options, ensuring that critical physiological data is continuously available to healthcare providers. The goal is to minimize complications and emergency hospitalizations while boosting overall patient satisfaction.
Broader Impact on Cancer Treatment
This collaboration represents a pioneering step towards transforming cancer care delivery. By integrating advanced technology into treatment plans, Veris Health and The Ohio State University aim to set a new standard in oncology, significantly improving patient experiences and treatment outcomes.
About PAVmed Inc.
PAVmed Inc. stands out as a versatile company in the medical technology space. With a commitment to developing effective solutions across diagnostics and digital health, it leverages innovation to enhance patient care. Its subsidiaries, including Veris Health and Lucid Diagnostics, are at the forefront of cancer prevention and treatment technologies, making substantial contributions to the healthcare landscape.
Contact Information
For further inquiries regarding the Veris platform and partnership details, interested cancer centers and practices are encouraged to contact PAVmed or Veris Health directly through their respective websites.
Frequently Asked Questions
What is the Veris Cancer Care Platform?
The Veris Cancer Care Platform is a digital health solution that integrates patient monitoring through remote data collection, symptom reporting, and telehealth functionalities.
How does this partnership enhance cancer care?
This partnership allows for a more personalized approach to cancer treatment, improving engagement and outcomes through continuous patient monitoring and data-driven insights.
What are Veris Health’s plans for future developments?
Veris Health is working on an implantable physiological monitor that will interface with their existing platforms to provide continuous data collection and monitoring capabilities.
Who else is involved in this partnership?
The partnership primarily involves PAVmed Inc., its subsidiary Veris Health, and The Ohio State University Comprehensive Cancer Center.
Where can I learn more about PAVmed and its subsidiaries?
Visit the official websites of PAVmed and Veris Health for more comprehensive information about their technologies and mission.
About The Author
Contact Dylan Bailey privately here. Or send an email with ATTN: Dylan Bailey as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.
